Core Viewpoint - The article highlights the significant performance of the pharmaceutical sector, particularly the integration of AI in healthcare, with notable stock price increases for companies like Ark Health and WuXi AppTec, indicating a positive market trend in this industry [2][10][16]. Group 1: Market Performance - On January 13, the Hong Kong stock market saw a rise, with the Hang Seng Index up by 0.9% to 26,848.47 points, and the market turnover increased to 315.92 billion HKD from 306.22 billion HKD the previous day [2]. - Among the constituents of the Hang Seng Index, 53 stocks rose while 33 fell, with WuXi AppTec increasing by 8.30% and WuXi Biologics by 5.85%, leading the blue-chip stocks [4][5]. Group 2: Individual Stock Highlights - WuXi AppTec's stock price rose to 120 HKD per share, marking an increase of 8.30%, driven by a profit forecast indicating a projected net profit growth of approximately 102.65% for 2025 [16][18]. - WuXi Biologics also saw a significant increase, closing at 39.78 HKD per share with a rise of 5.85%, supported by its announcement of attending the 44th Annual J.P. Morgan Healthcare Conference [21][24]. Group 3: AI Integration in Healthcare - Ark Health's stock surged by 76.37% during the day, closing at 3.93 HKD per share, following its collaboration with Tencent Health to enhance "AI + Chronic Disease Management" technology [10][13]. - The partnership aims to provide comprehensive support for the digital transformation of chronic disease management, leveraging both companies' strengths in technology and healthcare [13][14]. Group 4: Future Outlook - WuXi Biologics announced a record high of 209 new projects for 2025, with a total project count reaching 945, indicating strong growth potential and a robust pipeline [24][26]. - The company is optimistic about accelerating commercialization revenue growth in 2026, focusing on advanced technologies and global capacity expansion [26].

Group 1 - The report indicates that global markets mostly rose during the week of January 5-9, 2026, with the Hang Seng Index declining by 0.4% and the Hang Seng Tech Index down by 0.9% [1] - The healthcare sector led gains with a 10.1% increase, while telecommunications and information technology sectors faced declines of 2.3% and 1.6%, respectively [1] - The report highlights a significant inflow of southbound funds, totaling 32.65 billion HKD, although its proportion of total trading volume decreased from 51% to 45% [1][2] Group 2 - Investors show strong consensus on which Hong Kong stocks to buy, but there is a lack of consensus regarding potential short-term risks [3] - The report notes that expectations for a delay in the Federal Reserve's interest rate cuts could impact the rebound of Hong Kong stocks, with predictions suggesting only 1-2 rate cuts in 2026 [3] - Key risk factors include the potential ruling on the IEEPA Act and upcoming earnings reports from US tech companies, which could influence market sentiment [3][4] Group 3 - The report recommends maintaining a barbell strategy for overall portfolio allocation, suggesting a focus on value dividends as a base and aggressive positions in AI technology, non-ferrous metals, and innovative pharmaceuticals [4] - Upcoming events to watch include the JPM Healthcare Conference and key economic data releases from China and the US, which could impact market dynamics [5]

Group 1: A-Share Market - The A-share market showed strong performance this week, with significant increases in trading activity. The CSI 500, CSI 1000, and CSI 2000 indices rose by 7.92%, 7.03%, and 6.54% respectively, indicating a strong performance of small-cap stocks [3][7] - The market's upward trend was driven by increased risk appetite, with technology innovation sectors such as brain-computer interfaces, commercial aerospace, and AI applications becoming the main focus. Industries like electronics, computers, and defense received substantial capital inflows [5][7] - The average daily trading volume reached 2.85 trillion, a significant increase of 35.68% compared to the previous period [3][7] - The outlook for the A-share market remains positive, with expectations of continued upward momentum in the short term, particularly in the first quarter, driven by macroeconomic improvements and favorable policies [8] Group 2: Hong Kong Market - The Hong Kong market exhibited a weaker overall performance this week, with major indices such as the Hang Seng China Enterprises Index, Hang Seng Technology Index, and Hang Seng Index declining by 1.31%, 0.86%, and 0.41% respectively [9] - Despite the overall decline, there was structural differentiation within the market, with the healthcare sector leading gains at 10.06%, while telecommunications, information technology, and energy sectors underperformed [9] - The geopolitical situation, particularly U.S.-China relations, has influenced market sentiment, with recent announcements regarding increased U.S. defense spending impacting risk appetite [9] - Future expectations for the Hong Kong market suggest a potential recovery in the technology sector, influenced by the rising sentiment in the A-share technology sector and domestic economic recovery [9]

Group 1 - Elon Musk announced that Neuralink will start large-scale production of brain-machine interfaces in 2026, leading to a surge in related stocks in Hong Kong, particularly Nanjing Panda Electronics, which saw a peak increase of 49.48% [7][10] - The brain-machine interface sector is expected to experience significant growth, driven by policy support and technological breakthroughs, as indicated by research reports from Debon Securities and Open Source Securities [10] - The healthcare industry index in the Hang Seng Composite Industry Index rose by 3.94%, reflecting positive market sentiment towards biotech and related sectors [6] Group 2 - Kuaishou's stock price increased by 11.09%, reaching HKD 73.60 per share, with a trading volume of HKD 9.898 billion, following the release of its 2025 annual trend report [11][14] - The report highlighted that Kuaishou has an average of 260 million daily users engaging with trending content, with over 38.81 million user-generated trending videos created throughout the year [14] - First Shanghai issued a "buy" rating for Kuaishou, projecting revenue growth from RMB 142.22 billion in 2025 to RMB 165.42 billion in 2027, with net profits expected to rise correspondingly [17]

- Model Name: Guosen Hong Kong Stock Selection Portfolio; Model Construction Idea: The model aims to select stocks with both fundamental support and technical resonance from the analyst-recommended stock pool[17] - Model Construction Process: The model is constructed by first creating an analyst-recommended stock pool based on analyst earnings forecast upgrades, initial coverage by analysts, and unexpected events in analyst report titles. Then, stocks in the pool are selected based on both fundamental and technical dimensions. The backtest period is from January 1, 2010, to June 30, 2025. The annualized return of the portfolio is 19.11%, with an excess return of 18.48% relative to the Hang Seng Index[17] - Model Evaluation: The model effectively combines fundamental and technical analysis to select outperforming stocks[17] - Factor Name: 250-Day New High Distance; Factor Construction Idea: The factor measures the distance of the latest closing price from the highest closing price in the past 250 trading days[23] - Factor Construction Process: The 250-day new high distance is calculated as follows: $ 250 \text{ Day New High Distance} = 1 - \frac{Close_t}{ts\_max(Close, 250)} $ where $ Close_t $ is the latest closing price, and $ ts\_max(Close, 250) $ is the maximum closing price in the past 250 trading days. If the latest closing price is a new high, the distance is 0; otherwise, it is a positive value indicating the fallback magnitude[23] - Factor Evaluation: The factor effectively captures the momentum effect in the Hong Kong stock market[21][23] Model Backtest Results - Guosen Hong Kong Stock Selection Portfolio, Annualized Return: 19.11%, Excess Return: 18.48% relative to the Hang Seng Index[17] - Guosen Hong Kong Stock Selection Portfolio, 2025 Performance: Absolute Return: 53.23%, Excess Return: 25.46% relative to the Hang Seng Index[18] Factor Backtest Results - 250-Day New High Distance, Selected Stocks: Modern Dairy, etc., with the highest number of stocks in the cyclical sector[23][24]

Group 1 - The overall shareholding ratio of southbound funds in Hong Kong Stock Connect stocks is 19.34%, with 249 stocks having a shareholding ratio exceeding 20% [1] - As of December 30, southbound funds held a total of 4,925.70 million shares, accounting for 19.34% of the total share capital of the stocks, with a market value of 61,460.68 million HKD, representing 14.67% of the total market value [1] - The highest shareholding ratio by southbound funds is in China Telecom, with 9,997.50 million shares, representing 71.90% of the issued shares [2] Group 2 - Southbound funds with a shareholding ratio exceeding 20% are mainly concentrated in the healthcare, industrial, and financial sectors, with 56, 37, and 34 stocks respectively [2] - Among the stocks with over 20% shareholding by southbound funds, 129 are AH concept stocks, accounting for 51.81% [1] - The stock with the second-highest shareholding ratio is Green Power Environmental, with 28,290.80 million shares, representing 69.96% [2] Group 3 - The stock with the third-highest shareholding ratio is China Resources Power, with 36,689.50 million shares, representing 68.75% [2] - Other notable stocks with high southbound fund holdings include Kaisa Group, Tianjin Chuangye Environmental Protection, and China Shenhua, with shareholding ratios of 68.23%, 67.16%, and 66.39% respectively [2] - The data indicates a significant interest from mainland investors in Hong Kong stocks, particularly in sectors with strong growth potential [1][2]

Group 1 - European stock markets rose on Tuesday, driven by mining stocks as commodity prices increased, with investors awaiting the release of the Federal Reserve's recent meeting minutes [1] - The Stoxx Europe 600 index closed up 0.6%, while the German DAX index also rose by 0.6%, achieving its largest annual gain since 2019 due to optimism surrounding substantial fiscal stimulus measures [1] - The Italian FTSE MIB index outperformed other major European indices, rising by 1.1% and recording a cumulative gain of 32% for the year 2025, marking its best annual performance since 1998 [1] Group 2 - The mining sector increased by 1.7%, with copper prices on track for the longest consecutive rise since 2017, indicating strong demand in the sector [1] - Blue-chip Stoxx 50 index rose by 0.8%, closing at a record high for the first time since November [1] - Fresnillo Plc saw a significant increase of 6.8% after Citigroup analysts raised the target price for the company while maintaining a buy rating, citing rising silver and gold prices as a key factor [1]

- The "Hong Kong Stock Selection Portfolio" strategy is constructed based on a dual-layer selection process that combines fundamental and technical analysis. The initial stock pool is built using analyst recommendation events, such as upward earnings revisions, first-time coverage, and unexpected positive research report titles. From this pool, stocks with both fundamental support and technical resonance are selected to form the portfolio. The backtesting period is from January 1, 2010, to June 30, 2025, with an annualized return of 19.11% and an excess return of 18.48% relative to the Hang Seng Index after considering transaction costs in a fully invested state [14][16] - The "Stable New High Stock Screening" factor is constructed to identify stocks that have recently reached a 250-day high and exhibit stable price paths. The 250-day new high distance is calculated as follows: $ 250\text{-day new high distance} = 1 - \frac{Close_t}{ts\_max(Close, 250)} $ Where $ Close_t $ is the latest closing price, and $ ts\_max(Close, 250) $ is the maximum closing price over the past 250 trading days. A value of 0 indicates a new high, while positive values indicate a decline from the peak. Stocks are further filtered based on analyst attention (at least five buy or overweight ratings in the past six months), relative strength (top 20% in 250-day returns), price stability (evaluated using price path smoothness and 250-day new high distance averages over 120 days), and trend continuation (average 250-day new high distance over the past five days). The top 50 stocks are selected based on these criteria [23][24] - The backtesting results for the "Hong Kong Stock Selection Portfolio" show an annualized return of 19.11%, an excess return of 18.48% relative to the Hang Seng Index, and a maximum drawdown of 23.73% over the entire sample period. The information ratio (IR) is 1.22, with a tracking error of 14.55% and a return-to-drawdown ratio of 0.78 [20] - The "Stable New High Stock Screening" factor identified stocks primarily in the cyclical sector (9 stocks), followed by financials (4 stocks), technology (3 stocks), manufacturing (3 stocks), and consumer sectors (3 stocks) during the recent period. Specific stocks include Global New Material International and others [23][24]

Group 1 - As of December 17, the total shareholding of southbound funds in Hong Kong Stock Connect stocks accounts for 19.33% of the total share capital, with a total market value of HKD 60,627.61 billion [1] - There are 247 stocks where the shareholding ratio of southbound funds exceeds 20% [1] Group 2 - China Telecom has the highest shareholding ratio at 72.27%, followed by Gree Power and China Gas with 70.08% and 69.75% respectively [3] - The stocks with high southbound fund holdings are primarily concentrated in the healthcare, industrial, and financial sectors, with 56, 36, and 34 stocks respectively [3] - Over half of the stocks with high southbound fund holdings are AH concept stocks, with 128 out of the 247 stocks also listed in mainland China and Hong Kong, representing 51.82% [3]

Summary of the 2025 CFO Compensation White Paper Core Viewpoint The 2025 CFO Compensation White Paper focuses on the salary levels, influencing factors, and development trends of CFOs in the Hong Kong and A-share markets, revealing significant disparities in compensation between the two regions. Group 1: Compensation Overview - The average annual salary for CFOs in Hong Kong is 1.602 million RMB, with a median of 1.077 million RMB, while in A-shares, the average is 857,600 RMB and the median is 684,200 RMB, indicating that Hong Kong CFOs earn approximately 1.9 times more than their A-share counterparts [1][2]. - The total salary for CFOs in Hong Kong reached 630 million RMB in 2024, with a notable right-skewed distribution where a few high-earning CFOs significantly raise the average [38][41]. Group 2: Individual Characteristics Impacting Compensation - Gender distribution shows a predominance of male CFOs in both markets, with a ratio of approximately 7:3 in Hong Kong and 61% male in A-shares. Male CFOs earn more on average than female CFOs, although top female CFOs can match or exceed male salaries [2][44]. - Age plays a crucial role in salary, with CFOs aged 40-55 being the primary group. Salaries increase with age and experience, with those over 50 in Hong Kong reaching high salary levels [2][50]. Group 3: Industry and Company Characteristics - In Hong Kong, sectors such as consumer discretionary, healthcare, and information technology lead in CFO compensation, while in A-shares, finance and real estate offer the highest salaries [2][56]. - Larger companies with higher profitability tend to pay their CFOs more, with a positive correlation between asset size, revenue, and return on equity (ROE) with compensation levels [2][56]. - The average salary for CFOs in AH-share listed companies is particularly high at 3.05 million RMB, reflecting a 15% increase from 2023 [2][56]. Group 4: Trends and Future Outlook - The role of CFOs is evolving from traditional financial controllers to strategic leaders and digital transformation drivers, leading to changes in compensation structures [2][56]. - Over the next 3-5 years, overall CFO compensation growth is expected to moderate, but the premium for top-tier, multifaceted CFOs will continue to rise, with compensation increasingly tied to long-term incentives and performance metrics [2][56].